Table 2. The minimum inhibitory concentration (MIC) of dicentracin-like and moronecidin.
| Bacteria strains | Culture broth | Antimicrobial peptides((μg/ml) | |
|---|---|---|---|
| Gram-negative bacteria | Dicentracin-like | Moronecidin | |
| Escherichia coli (ATCC 25922) | Brain heart infusion | 4.68 | 9.37 |
| Pseudomonas aeruginosa (ATCC10662) | Brain heart infusion | 37.5 | 75 |
| Acinetobacterbaumannii(Clinical isolate) | Brain heart infusion | 18.75 | 37.5 |
| Gram-positive bacteria | |||
| Staphylococcus aureus(ATCC 25923) | Brain heart infusion | 4.68 | 2.34 |
| Staphylococcus epidermidis (ATCC 1435) | Brain heart infusion | 1.17 | 2.34 |
| Staphylococcus aureus(MRSA) | Brain heart infusion | 4.68 | 2.34 |
| Yeast | |||
| Candida albicans (clinical isolate) | RPMI medium | 4.68–9.37 | 9.37 |
| Candida tropicalis(clinical isolate) | RPMI medium | 4.68–9.37 | 9.37 |
| Candida glabrata(clinical isolate) | RPMI medium | >150 | >150 |